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Abstract  
High-grade endometrial stromal sarcoma is a rare uterine malignancy. The cells of these tumors 
resemble endometrial cells in the proliferation stage, with many small plexiform arterioles. Herein 
we present a patient with endometrial stromal sarcoma that metastasized to the brain, along with 
the CT and MRI findings and a discussion of the surgical and histopathological features of the 
metastatic tumor. Immunohistopathological examination of the metastatic tumor showed a high 
mitotic rate and strong immunopositivity for CD10 and vimentin (as a mesenchymal marker); 
therefore, the lesion was considered to be high-grade endometrial stromal sarcoma. Due to the 
rarity of reported cases of metastatic brain tumors of high-grade endometrial stromal sarcoma, 
there isn’t a standard treatment protocol; however, metastatic tumors of high-grade endometrial 
stromal sarcoma match the same general concepts of brain metastasis. In addition, endometrial 
stromal sarcomas may be associated with hemorrhagic metastasis to the brain due to their 
pathologic characteristics.  
 
 
 
 
 
 
 
 
 
 
 
Introduction 
The brain is a common site of metastases; 
about 170,000 patients are newly diagnosed with 
brain metastases each year in the USA [1]. The 
occurrence of metastatic brain tumors is 10-fold 
greater than that of newly diagnosed primary brain 
malignancies [1-4]. Lung, breast, renal, and colorectal 
carcinoma, and malignant melanoma commonly 
metastasize to the brain [1-4]. Apart from 
choriocarcinoma, female genital tract cancers are a 
rare source of metastatic brain tumors [1-4]. 
Metastasis from the female genital tract to the brain is 
characteristic of widespread disseminated disease [5]. 
A PubMed search using 12 different key words in 
addition to the term endometrial stromal sarcoma 
showed that there were only 4 reported cases of 
endometrial stromal sarcoma that metastasized to the 
brain. Three of these cases were treated nonsurgically 
and one of them surgically, but none of them showed 
no hemorrhagic features at their metastasis in the 
brain. Herein we present what to the best of our 
knowledge is the first hemorrhagic cerebral 
metastasis of endometrial stromal sarcoma that was 
treated surgically.  
 
Case Report 
A 50-year-old female underwent abdominal 
hysterectomy with bilateral salpingo-oopherectomy in 
july 2012. Histopathological examination of the 
hysterectomy specimen showed endometrial stromal 
sarcoma. Microscopic examination of the 
hysterectomy specimen showed widespread invasion 
of the tumor into the vascular channels within the 
myometrium (Figures 1a, b). Adjuvant chemotherapy 
was initiated following abdominal hysterectomy. She 
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presented to our hospital in April 26 2013 with abrupt 
onset of left-sided loss of power; she could not walk, 
or use her left arm and left hand. Her left arm was 
affected to a greater degree than her left leg. Her left 
leg power was 3/5, whereas her left arm power was 
2/5. The patient’s Glasgow Coma Scale score was 
15/15 at the time of presentation. 
 
Figure 1: a) Hysterectomy specimen shows myometrial invasion by 
high-grade endometrial stromal sarcoma (H&E, 100). b) The black 
arrows indicate widespread tumoral invasion of the vascular 
channels within the myometrium (H&E, 40). 
 
Cranial computed tomography (CCT) showed 
a lesion located in the right frontoparietal region 
(including the motor cortex) that appeared hyperdense 
with a perilesional hypodense area (Figure 2a, b). We 
then performed cranial magnetic resonance imaging 
(MRI), which showed heterogeneous contrast 
enhancement of the lesion in the right frontoparietal 
region. T1-weighted MRI showed that the legion 
extended into the right motor cortex at the right 
precentral gyrus. In addition, T2-weighted MRI 
showed perilesional edema (Figure 3a, b, c). 
Following the diagnosis of intracranial lesion, 
abdominal and thoracic computed tomography was 
performed and the findings were negative for 
metastasis. The patient’s routine laboratory test 
results were normal.  
 
Figure 2: Axial (a), and coronal (b) non-contrast-enhanced CT 
shows a hematoma in the right frontoparietal lobe surrounded by 
hypodense edema. 
 
The patient underwent frontoparietal 
craniotomy, with gross total extirpation of the tumor 
located in the right frontoparietal region in April 27 
2013. The paracentral intersulcal region was incised 
at the parietal lobe and the tumor was located in the 
cortex at a depth of 5 mm. Firstly, the hemorrhagic 
part of the tumor was aspirated, and then the wall of 
the tumoral cavity (all the way to the glial tissue) was 
aspirated. The tumoral tissue was hemorrhagic and 
infiltrated the glial tissue, with no obvious border 
between the tumor and glial tissue. It is noteworthy 
that the tumor was hemorrhagic, but that there wasn’t 
any unusual bleeding during tumor removal. Lastly, 
bleeding in the surgical region was controlled and the 
cranium was closed in the typical manner. The patient 
was awakened and her left leg motor function was the 
same as pre surgery, but her left arm motor function 
was weaker than during the preoperative period - it 
was virtually plegic. She began to move the proximal 
part of her left arm and forearm postoperative second 
day, but could not move her left hand or fingers. We 
performed cranial MRI 24 h post-surgery; contrast-
enhanced T1-weighted MRI showed that there was no 
residual lesion. T2-weighted MRI showed that there 
was no edema (Figure 3 d, e, f). 
 
Figure 3: a, b, c: T2-weighted MRI; the lesion measured 34  39  
36 mm in 3 different sections. The lesion shows heterogeneous 
intensity surrounded by hyperintense edema, and it was located in 
the right frontoparietal lobe. In addition, it occupied the hand region 
of the right motor cortex; d, e, f: T2-weighted MRI shows no edema, 
but there is a hyperintense appearance in area from which the 
metastatic brain tumor was removed. 
 
Histopathological examination findings of the 
brain lesion specimen were consistent with 
endometrial stromal sarcoma (Figures 4a, b). Gross 
examination of the excised specimen showed a 2  4-
cm yellow/cream-colored fragmented fragile mass 
with areas of necrosis and hemorrhage. Microscopic 
evaluation showed a metastatic malign mesenchymal 
neoplasm that had infiltrative margins, with several 
invasion foci into the adjacent glial tissue exhibiting 
marked reactive gliosis (Figure 4a, b). The neoplasm 
was composed of short bundles of ovoid to spindly 
cells, with marked nuclear anaplasia and scattered 
tumor giant cells (Figure 4b, c). There was remarkable 
arborizing and pericytomatous vasculature, 
widespread necrosis and hemorrhagic areas, and high 
mitotic activity (Figure 4c). The metastatic brain 
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neoplasm was strongly immunopositive for CD10 and 
vimentin, but was negative for CD34, smooth muscle 
actin, and cytokeratin AE1/AE3 (Figure 4d). The 
patient was scheduled to undergo radiotherapy and 
chemotherapy, but these adjuvant therapies are 
beyond of the scope for this case report. 
 
Figure 4: (a) Metastatic undifferentiated endometrial stromal 
sarcoma in the brain. Infiltrative neoplastic cell groups in the 
adjacent glial tissue (lower right side) show marked reactive gliosis 
(H&E, 100); (b) a close-up view of neoplastic ovoid to spindly cells, 
with anaplasia and neoplastic giant cells (white arrows) in the 
infiltrative tumor margin and reactive gliosis (H&E, 400); (c) the 
metastatic brain tumor exhibits a hemangiopericytomatous vascular 
pattern, with widespread necrosis and hemorrhage (H&E, 100); (d) 
the metastatic mesenchymal neoplasm in the brain was strongly 
immunopositive for CD10 (200). 
 
Discussion 
Metastasis of female genital tract cancers 
occurs less frequently than in cases of other tumors, 
including lung, breast, renal, and colorectal 
carcinoma, and malignant melanoma. Endometrial 
stromal sarcoma is a rare tumor of the female genital 
tract; there are only approximately 450 new cases 
annually in the USA [1, 6]. Endometrial stromal 
sarcomas are histologically classified as low-grade or 
high-grade on the basis of the rate of mitosis [7-9]. 
Patients with low-grade endometrial stromal sarcoma 
have a 5-year survival rate of 65%, versus <25% in 
those with high-grade disease [10, 11]. Brain 
metastasis of endometrial stromal sarcoma is also 
rare because of the rarity of the tumor [1, 6]. Genital 
tract cancers metastasize to the brain primarily via the 
hematogenous route [12]. Tumor cells that separate 
from the genital tract travel to the brain via the blood 
stream, through the inferior vena cava, right atrium, 
right ventricle, pulmonary artery, lungs, pulmonary 
veins, left atrium, left ventricle, and aorta [12, 13]. In 
addition, the Batson plexus (paravertebral venous 
plexus) is another route of dissemination of genital 
tract tumors [12, 13]. 
Microscopic examination of the presented 
patient’s hysterectomy specimen showed that there 
was widespread invasion into the vascular channels 
within the myometrium (Figures 1a, b), which is 
evidence of hematogenous spread of the endometrial 
stromal sarcoma; however, the metastatic lesion’s 
features was similar to that of a subacute intracerebral 
hematoma, as it was observed to be surrounded by 
edema via cranial CT. We think that the hemorrhagic 
appearance was due to the histopathological features 
that are characteristic of endometrial stromal 
sarcomas, as these tumors’ cells resemble 
endometrial cells in the proliferation stage, with many 
small plexiform arterioles [2]. In addition, 
histopathology of the presented case showed 
arborizing and pericytomatous vasculature, which has 
been reported earlier (Figure 4a, b, c).  
Cranial metastasis of endometrial stromal 
sarcoma has been reported 4 times by different 
authors until now. One case had metastasis in the 
sphenoid bone and lumbar spine [14], another case 
had lung and cerebral metastasis [15], and the third 
case had multiple cerebral metastases [16]. The last 
case has been recently reported in 2013, and the 
patient in this case had a lesion mimicking 
meningioma and located at right occipital lobe [17]. 
This lesion was successfully extracted from the 
occipital lobe [17]. Our case is 5
th
 case presented in 
the literature, and it is second case underwent 
surgery. However our presented case is the first 
reported case of hemorrhagic brain metastasis of 
endometrial stromal sarcoma underwent surgery. 
Histopathological examination of the specimen taken 
from the cerebrum also showed that the metastatic 
lesion was endometrial stromal sarcoma; however, 
extrauterine high-grade endometrial stromal sarcoma 
can be diagnostically challenging. In the presented 
case the pathologists performed immunohisto-
chemical analysis in order to differentiate the 
endometrial stromal sarcoma from several soft tissue 
neoplasms with a hemangiopericytomatous vascular 
pattern. CD10 is a sensitive and diagnostically useful 
marker of endometrial stromal tumors [18]. The 
uterine tumor and metastatic tumor cells in the 
presented case exhibited strong immunopositivity for 
CD10 and vimentin (as a mesenchymal marker) [18]; 
this immune profile supported the diagnosis of 
endometrial stromal sarcoma. All of the presented 
patient’s histopathological findings were consistent 
with endometrial stromal sarcoma.  
 In conclusion, in patients with endometrial 
stromal sarcoma cranial CT may show the presence 
of hemorrhagic metastasis and perilesional edema. In 
such cases contrast-enhanced MRI must be 
performed to differentiate between a hemorrhagic 
mass lesion and a hematoma of the cerebrum. Then, 
whether or not surgical treatment is necessary can be 
determined on the basis of the same general concepts 
of brain metastasis. 
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